ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Noxxon Pharma NV

Noxxon Pharma NV (ALTME)

0.146
-0.012
(-7.59%)
Cerrado 04 Noviembre 10:30AM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
0.146
Postura de Compra
0.141
Postura de Venta
0.1458
Volume Operado de la Acción
1,020,758
0.14 Rango del Día 0.1592
0.1124 Rango de 52 semanas 0.47
Capitalización de Mercado [m]
Precio Anterior
0.158
Precio de Apertura
0.1582
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
432,428
Acciones en circulación
28,453,373
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.63
Beneficio por acción (BPA)
-0.24
turnover
17k
Beneficio neto
-6.74M

Acerca de Noxxon Pharma NV

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Berlin, Deu
Fundado
-
Noxxon Pharma NV is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALTME. The last closing price for Noxxon Pharma NV was 0.16 €. Over the last year, Noxxon Pharma NV shares have traded in a share price range of 0.1124 € to 0.47 €.

Noxxon Pharma NV currently has 28,453,373 shares in issue. The market capitalisation of Noxxon Pharma NV is 4.50 € million. Noxxon Pharma NV has a price to earnings ratio (PE ratio) of -0.63.

ALTME Últimas noticias

TME Pharma kündigt strategischen Plan zur Externalisierung und Monetarisierung von NOX-E36, einem Produkt der zweiten klinischen Phase, an

NOX-E36 bietet vielversprechende Entwicklungsmöglichkeiten für Augenkrankheiten mit einem hohen Bedarf an gut verträglichen Therapien mit antifibrotischer Wirkung Die antifibrotische...

TME Pharma Announces Strategic Plan to Externalize and Monetize Second Clinical Stage Asset NOX-E36

NOX-E36 presents promising opportunity for development in eye diseases with a high need for well-tolerated therapies with anti-fibrotic effect Anti-fibrotic mode of action of NOX-E36 was...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.00664.734576757530.13940.180.12610016900.15807168DE
40.02116.80.1250.180.11244028200.14854925DE
12-0.0016-1.084010840110.14760.180.11244324280.14661694DE
26-0.104-41.60.250.260.11243560860.15962631DE
52-0.244-62.56410256410.390.470.11246126000.25196585DE
1560.1042249.2822966510.04185.980.03983179080.35703849DE
2600.1042249.2822966510.04185.980.03983179080.35703849DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALNEVNeovacs
0.0003 €
(50.00%)
26.06M
ALVIAVialife Sa
20.00 €
(42.86%)
50
EBUSEbusco Holding NV
2.7405 €
(29.57%)
884.29k
CNVCnova NV
0.13 €
(26.83%)
1.09k
MLFTIFrance Tourisme Immobilier
0.044 €
(25.71%)
300
ALALOAcheterLouerFR
0.70 €
(-65.00%)
14.37k
TMBSZTME Pharma NV
0.03 €
(-39.88%)
193.46k
ALAVEAventador
0.0012 €
(-33.33%)
43.98M
ALIMOGroupimo
0.20 €
(-31.51%)
39
NYRNyrstar NV
0.12 €
(-17.24%)
384.27k
BCPBanco Comercial Portugues SA
0.451 €
(-2.61%)
83.35M
ALAVEAventador
0.0012 €
(-33.33%)
43.98M
ALNEVNeovacs
0.0003 €
(50.00%)
26.06M
ALDOLDolfines
0.0005 €
(-16.67%)
22.5M
ALNRGEnergisme SA
0.0065 €
(-1.52%)
15.49M
kayak_wench kayak_wench 4 minutos hace
If you are too petty to list everyone’s guesses you shouldn’t be doing the gathering of data. Total putz and childish approach to dealing with those you don’t agree. Holding grudges is for losers.
ELTP
waterchaser waterchaser 4 minutos hace
Your caps/bold keys are stuck.
HIRU
georgie18 georgie18 4 minutos hace
Ticker Owner Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
IDAI DQI Holdings Inc. 10% Owner Oct 28 '24 Buy 0.22 1,363,636 300,000 5,961,337 Nov 04 02:08 PM
IDAI
Huggy Bear Huggy Bear 5 minutos hace
This serial mining scam has never been anything BUT a highly promoted fraud.
NBRI
barmarty barmarty 5 minutos hace
whats going on
APRU
Davlund Davlund 5 minutos hace
I'm sure NexPoint sees some value in this REIT for themselves and their shareholders or they never would have gotten involved in this. Are they looking out for the interest of longtime shareholders? I'm not so sure, but with them, "we don't know what we don't know. I'm willing to take that chance
Humbert Humbert 5 minutos hace
It'll take off once the financials are posted; we have many eyes on this.

Trust me, traders here & on Twitter know all about it - they're just waiting for confirmation. We're in a gray zone, informationally, though I've no doubts myself. BNCM will deliver, pursue IR, and it'll take of
BNCM
Penny Stocks 2.0 Penny Stocks 2.0 5 minutos hace
$ABIT .045 Falling Just Hired a CTO, COO and FGMK LLC as their Accounting firm
ABIT
georgie18 georgie18 5 minutos hace
IDAI...24...
Ticker Owner Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
IDAI DQI Holdings Inc. 10% Owner Oct 28 '24 Buy 0.22 1,363,636 300,000 5,961,337 Nov 04 02:08 PM
IDAI
Lime Time Lime Time 5 minutos hace
No fills
BCAP
Penny Stocks 2.0 Penny Stocks 2.0 5 minutos hace
$ABIT .045 Falling Just Hired a CTO, COO and FGMK LLC as their Accounting firm
ABIT
JayFiore JayFiore 5 minutos hace
So are you of the opinion that Blum should remain silent until there is progress to share? IMO he should at least put something out on X saying something to the effect that they are circling back with FINRA check on the status of the name change, etc.
SMCE
lakers17 lakers17 5 minutos hace
MINUTE entry before the Honorable Mary M. Rowland: The Court has reviewed the Temporary Receiver's initial status report [232]. The Court sets a status hearing for 11/7/24 at 2:00 PM Central time via Webex. The proposed intervenor is encouraged to attend. Counsel will receive an email with a link to
NSAV
Nemesis18 Nemesis18 6 minutos hace
As I predicted year ago here, and warned you all about, this application became derailed almost immediately upon receipt by the UK Regulator, and that the MAA would not be granted. !

I also warned you to take out as much of your hard-earned invested monies because you all suffered a t
NWBO
Beerworld Beerworld 6 minutos hace
Spare me. When T says he wants the dying to stop in Ukraine what he means is give some land to Putin. You think that will satisfy Putin?
janice shell janice shell 6 minutos hace
Yes. I think it'd be REALLY good.
Wishthiswasmyjob Wishthiswasmyjob 6 minutos hace
Election is tomorrow -
At this time, we have huge gov't, and outrageous spending, holding it all up -
Soon it will end,
If Kamala wins, we continue on the path of the last 3 years - destroying the nation.
If Trump wins, the "powers that be" will do everything they can
TruckingAngler TruckingAngler 6 minutos hace
I doubled down on CALC also.
News of released shares isn't intimidating. yet...
GLTA
CALC
sharkey1 sharkey1 6 minutos hace
https://www.youtube.com/watch?v=A4UcUTx2j4k
ELTP
I-Glow I-Glow 6 minutos hace
I posted the answer but you have blinders on.

"This is trying to answer the following questions:

A. Any affiliation or partnership between JP3E (JP 3E Holdings Inc.) and ArcLight Capital Partners ?

B. How BIG is JP3E relating to US and global business ?
SPZI
Menace212 Menace212 6 minutos hace
Ur off by 500 million buddy
RSPI
Monksdream Monksdream 7 minutos hace
IIPR, 10Q 11/6
https://investorshub.advfn.com/uimage/uploads/2024/11/4/ohj[rIMG_3059.gif
IIPR
georgeofthebungle georgeofthebungle 7 minutos hace
I had thought they were out finally. My mistake 
AFFU
Curt D Curt D 7 minutos hace
I hope it means they're getting close to done.
RDAR